Researchers from Saint Louis University and NIDDK discovered activating a mitochondrial adenosine receptor (A3AR) protects rodent neurons from chemotherapy-induced neurotoxicity (CIPN), a common cause of nerve pain in cancer patients jneurosci.org/content/early/… SfN Journals

💥🆙Consensus practice infection control guidelines for regional anesthesia and pain medicine 🆕💥 🆓🖇️ rapm.bmj.com/content/early/… 🔥Huge works, massive article with 50 pages, 700 references 🔥 🔺state-of- the-art …article🔺 David Provenzano, MD Congrats to All Authors ASRA Pain Medicine 👏

⚠️ 🚨 The Guidelines We've All Been Waiting For! 🚨⚠️ What to do for infection control in RAAPM bit.ly/3EdKeOQ David Provenzano, MD, Kelly Cawcutt MD MS, Tina Doshi, RLJohnson, 🩺 Hari (హరి 🇮🇳) Kalagara, Sandy Kopp, Alan Macfarlane, @amypearsonmd, Eellan Sivanesan, MD, FASA, Rakesh Sondekoppam, Samer Narouze,MD,PhD,MMM

In Science Magazine today, the discovery of the neuroimmune itch-scratch circuit. And why scratching can make things worse science.org/doi/10.1126/sc… science.org/doi/10.1126/sc…

FDA approves new non-opioid pain drug tinyurl.com/3zxb6vrd The FDA has approved Vertex’s suzetrigine, an oral inhibitor of the ion channel NaV1.8, for the treatment of moderate to severe acute pain, providing a much-needed new option Background here tinyurl.com/5x7zyduj

Breaking News: The FDA approved a new medication to treat pain from an injury or surgery. Unlike opioid pain medicines, it cannot become addictive. nyti.ms/4jvz9J4

ASRA Pain Medicine consensus practice infection control guidelines for regional anesthesia and pain medicine rapm.bmj.com/content/early/… ASRA Pain Medicine Regional Anesthesia & Pain Medicine David Provenzano, MD Sandy Kopp Tina Doshi Amy Pearson, MD, FASA Dr Amit Pawa💉🎙️ Alan Macfarlane 🩺 Hari (హరి 🇮🇳) Kalagara Samer Narouze,MD,PhD,MMM Eellan Sivanesan, MD, FASA

Norepinephrine and CXCL16 are co-released from the terminals of sympathetic nerve fibres in the dorsal root ganglion & synergistically contribute to the maintenance of neuropathic pain #pain #laboratory #cytokines bjanaesthesia.org/article/S0007-…

We are sad to announce that Dr. Ronald D. Miller has passed away. He served as our chair from 1984 until 2008, and was one of the most successful physician-scientist-leaders in the field’s history. Read more about his remarkable life and legacy: anesthesia.ucsf.edu/news/rememberi…

🚨Time to rethink the SCS trial-to-implant ratio?🚨 With recent implant rates >80%, are trial-to-implant ratios are still meaningful? Or is it time to update utilization metrics to include explant and per-capita ratios? Eellan Sivanesan, MD, FASA Ryan D'Souza, MD bit.ly/3QSdihN

MEMBER SPOTLIGHT: Eellan Sivanesan, MD, FASA is shaping the future of #neuromodulation! 🔬✨ As Director of Neuromodulation at Johns Hopkins Medicine, he is dedicated to leveraging #neurostimulation for patients with chronic pain & non-traditional indications. Read more: neuromodulation.org/member-sivanes…

So pleased this one now out with the amazing Sarah Garfinkel Interoception and pain: body–mind integration, rupture, and ... : PAIN journals.lww.com/pain/fulltext/…

What do you think the next step will be in mechanism-based nonopioid analgesic #painmanagement? Zeng et al. review the challenges and breakthroughs, as well as the need for pharmacodynamically distinct multimodal interventions in Journal of Clinical Investigation bit.ly/44cmzJ8 #PRF

Nearly 19 million U.S. children—1 in 4—lived with at least one parent or primary caregiver who had a substance use disorder in 2023. The findings highlight the need for treatment for parents and interventions for families affected by substance use disorders.

The U.S. FDA has created a new program that will speed up the approval of new drugs before clinical trials are even completed, and without the usual oversight by FDA staff and advisors. What could possibly go wrong? Dr. Marty Makary bit.ly/4jXhsB5

It is unbelievable that when I started my lab 11 years ago people referred to itch as a "niche" therapeutic domain. Look at the monthly Rx of Ebglyss and Adbry (anti-IL-13 mAb) and Nemluvio (anti-IL-31RA mAb) since launch. Dupixent (anti-IL-4R mAb) is not on this chart because

Just arrived in my office-3rd edition of my book. New chapters, my original art, patient stories, and case studies. Available in September....#kathleensluka #slukaart #painscience ⁦UIowa PTRS⁩ ⁦University of Iowa Health Care⁩ ⁦Carver College of Medicine⁩ ⁦Iowa Neuroscience Institute⁩

#regionalanesthesia #pain ASRA Pain Medicine Consensus Practice Infection Control guidelines: 👇🏿 Check out: rapm.bmj.com/content/early/… David Provenzano, MD Full article: rapm.bmj.com/content/early/… Samer Narouze,MD,PhD,MMM Regional Anesthesia & Pain Medicine Dr. Vishal Uppal MBBS, FRCA 🇨🇦🇮🇳🏴󠁧󠁢󠁳󠁣󠁴󠁿 Mayo Clinic Pain Medicine ESRA | European Society of Regional Anaesthesia Tina Doshi Rakesh Sondekoppam

💊 Lost in conversion? Converting intrathecal to oral opioids isn't as simple as 1:300. This RAPM case report shows: 🧩 Real-life ratios = 1:2 to 1:12 ⚠️ 1:300 may be dangerously outdated 🔗 doi.org/10.1136/rapm-2… By @talktoratan Eellan Sivanesan, MD, FASA #Opioids #RAPM

Chronic pain remains a major challenge—despite scientific progress, many patients still face delays, stigma, and limited options. I spoke with Newsweek about why better science hasn’t always led to better care. newsweek.com/2025/08/22/chr… #ChronicPain #PainResearch #HealthPolicy